Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

YUMANITY THERAPEUTICS

(YMTX)
End-of-day quote Nasdaq  -  2022-12-18
4.950 USD   -62.59%
01/05Yumanity Therapeutics : January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA (Nasdaq) - Form 8-K
PU
2022Yumanity Therapeutics : Kineta Completes Reverse Merger with Yumanity Therapeutics - Form 8-K
PU
2022Kineta's Shares Gain Momentum on Nasdaq Debut Following Yumanity Therapeutics Reverse Merger Completion
MT
SummaryQuotesChartsNewsRatingsCompanyFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Yumanity Therapeutics to Pay Special Cash Dividend Related to Planned Asset Sale, Kineta Merger -- Shares Rise

12/05/2022 | 11:43am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON 0.88% 163.42 Delayed Quote.-7.49%
All news about YUMANITY THERAPEUTICS
01/05Yumanity Therapeutics : January 2023 Developing next-generation immunotherapies that addre..
PU
2022Yumanity Therapeutics : Kineta Completes Reverse Merger with Yumanity Therapeutics - Form ..
PU
2022Kineta's Shares Gain Momentum on Nasdaq Debut Following Yumanity Therapeutics Reverse M..
MT
2022Kineta, Yumanity Therapeutics Complete Reverse Merger
MT
2022Kineta, Inc. completed the acquisition of Yumanity ..
CI
2022YUMANITY THERAPEUTICS, INC. Other Events (form 8-K/A)
AQ
2022Yumanity Therapeutics Inc.(NasdaqCM:KA) dropped from..
CI
2022Yumanity Therapeutics : Acquisition/Asset Disposal - Form 8-K
PU
2022Yumanity Therapeutics, Inc. : Completion of Acquisition or Disposition of Assets, Other Ev..
AQ
2022Sector Update: Health Care Stocks Stage Small Recovery Late
MT
More news
Analyst Recommendations on YUMANITY THERAPEUTICS
More recommendations
Chart YUMANITY THERAPEUTICS
Duration : Period :
Yumanity Therapeutics Technical Analysis Chart | MarketScreener
Full-screen chart